The Orofacial Pain Prospective Evaluation and Risk Assessment II will follow up with 3,200 patients from the OPPERA I program and enroll 3,000 new patients to understand conditions such as jaw-related disorders, headaches, irritable bowel syndrome and lower back pain.
Researchers will assess the patients’ behaviors, genetic factors and other biological mechanisms that could contribute to chronic pain conditions, according to the report.
More Article on Pain Management:
5 Statistics on Chiropractic Use for Medicare Patients
Chronic Pain Management Costs $625B Annually
Dr. Sarah Knievel Joins Mohave Pain Management
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
